Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)643.57
  • Today's Change11.57 / 1.83%
  • Shares traded19.44k
  • 1 Year change-2.19%
  • Beta0.1752
Data delayed at least 20 minutes, as of May 03 2024 14:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies addressing an unmet medical need. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have growth prospects, with experienced management and strong potential upside through the development and/or commercialization of a pharmaceutical product, device or enabling technology. The Company’s investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).

  • Revenue in GBP (TTM)12.06m
  • Net income in GBP6.81m
  • Incorporated1994
  • Employees0.00
  • Location
    International Biotechnology Trust6th Floor, 65 Gresham Street,LONDON EC2V 7NQUnited KingdomGBR
  • Phone+44 207 421 7070
  • Websitehttps://ibtplc.com/
More ▼

Profile

Management group(s)Schroder Unit Trusts Limited
AIC sectorBiotechnology & Healthcare
ISINGB0004559349
Launch date06 May 1994
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Managed by

Ailsa Craig, Marek Poszepczynski

Management & contract fees

Management fee payable monthly at the rate of 0.9% p.a. of the NAV. The performance fee on the unquoted pool is 20% of net realised gain; performance fee on the quoted pool is 10% of relative outperformance above the sterling-adjusted NBI plus a 0.5% hurdle. Investment Management Agreement is terminable by either party on 12 months’ written notice.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Schroder Real Estate Investment Trst Ltd26.11m-53.92m218.14m0.00--0.737--8.36-0.1102-0.11020.05340.60520.0504--7.04---10.420.9147-10.630.930791.5590.25-206.5318.64--0.25870.3729289.003.33-0.2806-161.22----3.46
Baronsmead Second Venture Trust PLC-1.20m-6.91m219.95m0.00--0.9503-----0.0201-0.0201-0.00350.5788-0.0057-------3.25-0.8556-3.27-0.8628---28.02---45.58----0.00--97.26--86.16-----9.71
abrdn Diversified Income and Growth PLC5.91m-299.00k231.37m0.00--0.6814--39.14-0.0014-0.00140.01941.130.0158--2.69---0.07991.12-0.08141.1463.2244.08-5.0632.42----0.0443359.0925.66-17.7057.83----1.63
International Biotechnology Trust Plc12.06m6.81m238.31m0.0038.440.9193--19.760.16440.16440.29726.880.0382--1.47--2.163.202.453.4470.4378.6056.4969.29----0.1073116.43167.15-12.13130.32-19.34--0.4326
Baillie Gifford UK Growth Trust PLC3.13m313.00k239.09m0.001,263.570.9643--76.390.00130.00130.02081.690.0114--13.85--0.11440.36360.12170.369527.0951.4010.0035.18----0.0606466.14108.55-29.67103.90-38.47---9.71
Aquila European Renewables PLC-21.56m-25.59m239.97m----0.7526-----0.0658-0.0658-0.05490.8432-0.0608-------7.22---7.26-------------29,897.000.00---142.77---155.26------
abrdn European Logistics Income PLC36.01m-70.01m242.60m0.00--0.7364--6.74-0.1699-0.16990.08740.79930.0557--3.80---10.82-0.0171-11.06-0.017672.7176.96-194.44-0.3388--0.19380.4219--14.9575.40-343.56------
British Smaller Companies VCT plc15.21m11.99m244.20m0.0013.050.9752--16.060.06130.06130.07110.82030.0852------6.7211.196.7211.2380.4685.7578.8582.25----0.0086.64-51.5721.56-56.7029.47--0.8548
JPMorgan US Smaller Co Inv Trust PLC16.46m11.79m245.97m0.0021.450.8959--14.940.18320.18320.25544.390.0547--46.17--3.917.684.268.1978.5889.1571.6085.11----0.007.90177.43--147.09----3.71
Hansa Investment Company Ltd34.64m30.02m246.40m0.008.350.6616--7.110.25140.25140.29023.170.0941--12.14--8.153.928.163.9491.7585.4686.6577.35----0.0028.47-133.43---164.09-----27.52
Manchester & London Investment Trust plc107.72m104.00m246.79m0.002.370.9044--2.292.592.592.686.790.4719--596.80--45.562.6846.462.8797.1570.4196.5462.63----0.0097.36192.45-2.17147.011.42--3.13
Martin Currie Global Portfolio Trust PLC28.46m26.08m251.22m0.0010.441.01--8.830.34950.34950.38473.600.1038--20.33--9.517.1110.307.3394.2789.7091.6286.36----0.037516.34203.9539.10187.6551.42----
Starwood European Real Estate Financ Ltd34.96m25.25m251.27m0.0011.660.7676--7.190.07970.07970.10731.210.0913------6.606.076.626.1088.3385.7172.2478.87----0.0096.81-3.981.52-13.99-0.7167---3.49
Castelnau Group Ltd9.98m-7.78m254.91m4.00--1.1033.8725.54-0.0393-0.03930.03960.72580.0464--38.242,495,180.00-3.61---4.18---8.18---77.90------0.1709--133.43--77.19------
CC Japan Income and Growth Trust PLC41.93m38.34m255.31m0.006.661.09--6.090.28460.28460.31121.750.1879--10.25--17.186.2917.486.4195.9190.5691.4480.26--1,974.850.0048.68543.7253.47397.4977.70--7.16
Montanaro European Smllr Cmpns Trst PLC32.88m29.03m257.62m0.008.880.9819--7.830.15320.15320.17361.390.1263--40.25--11.159.4211.479.6592.0691.1788.2787.57----0.03177.16-187.25---228.10------
Data as of May 03 2024. Currency figures normalised to International Biotechnology Trust's reporting currency: UK Pound GBX

Institutional shareholders

62.66%Per cent of shares held by top holders
HolderShares% Held
Interactive Investor Services Ltd.as of 31 Aug 20235.34m14.05%
Hargreaves Lansdown Asset Management Ltd.as of 31 Aug 20235.23m13.74%
Legal & General Investment Management Ltd.as of 01 Feb 20243.04m8.01%
Border to Coast Pensions Partnership Ltd.as of 31 Aug 20232.54m6.67%
Charles Stanley & Co. Ltd. (Investment Management)as of 14 Mar 20241.87m4.92%
South Yorkshire Pensions Authorityas of 31 Aug 20231.65m4.34%
Brewin Dolphin Ltd.as of 31 Aug 20231.32m3.47%
West Yorkshire Pension Fundas of 31 Aug 20231.25m3.28%
Rathbones Investment Management Ltd.as of 01 Feb 2024880.00k2.31%
Wise Funds Ltd.as of 29 Dec 2023713.51k1.88%
More ▼
Data from 31 Mar 2023 - 02 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.